SCHEMBL7021773

SCHEMBL7021773

Cc1cc(O)nc(N[C@@H](C)c2ccccc2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDH1 O75874 2/20 0.48
TTK P33981 1/20 0.46
LMNA P02545 1/20 0.46
HTR7 P34969 5/20 0.44
HDAC3 O15379 3/20 0.43
HDAC1 Q13547 3/20 0.43
HDAC2 Q92769 3/20 0.43
HDAC6 Q9UBN7 3/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
LCK P06239 1/20 0.43
NUDT1 P36639 1/20 0.42
ADORA2A P29274 1/20 0.41
ADORA2B P29275 1/20 0.41
MAPK14 Q16539 1/20 0.41
ADRA1D P25100 1/20 0.40
ADRA1A P35348 1/20 0.40
ADRA1B P35368 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7594415 1.00 IDH1 (0.48) IDH1TTKLMNAHTR7HDAC3
SCHEMBL7018923 0.81 IDH1 (0.51) IDH1TTKLMNAHTR7HDAC3
SCHEMBL9698795 0.75 HTR7 (0.62) IDH1LMNAHTR7HDAC3HDAC1
SCHEMBL14629467 0.74 HTR7 (0.57) IDH1HTR7LCKMAPK14ADRA1D
SCHEMBL7016449 0.73 IDH1 (0.55) IDH1HTR7HDAC3HDAC1HDAC2
SCHEMBL14830995 0.73 IDH1 (0.54) IDH1HTR7HDAC3HDAC1HDAC2
SCHEMBL29019057 0.73 SMN1; SMN2 (0.61) LMNAMEN1NPC1RAB9AKMT2A
SCHEMBL14830994 0.73 IDH1 (0.54) IDH1HTR7HDAC3HDAC1HDAC2
SCHEMBL12289009 0.72 LMNA (0.63) IDH1LMNAMEN1KMT2AALDH1A1
SCHEMBL14936831 0.72 LMNA (0.63) IDH1LMNAMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1206265-B1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2003-11-12 EP disclosed
US-6498165-B1 PYRIMIDINE COMPOUNDS; PROPHYLAXIS AND TREATMENT OF SUCH AS IMMUNE DISEASES, HYPERPROLIFERATIVE DISORDERS, CANCER, ANGIOGENSIS, ATHEROSCELEROSIS, GRAFT REJECTION, RHEUMATOID ARTHRITIS, PSORIASIS MERCK & CO., INC. 2002-12-24 US disclosed
EP-1206265-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-08-07 EP disclosed
EP-1206265-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-05-22 EP disclosed
WO-2001000213-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 WO disclosed